Literature DB >> 17581882

Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis.

Berna S Sayan1, A Emre Sayan, Ai Li Yang, Rami I Aqeilan, Eleonora Candi, Gerald M Cohen, Richard A Knight, Carlo M Croce, Gerry Melino.   

Abstract

p63 is a p53-related transcription factor. Utilization of two different promoters and alternative splicing at the C terminus lead to generation of six isoforms. The alpha isoforms of TAp63 and DeltaNp63 contain a transactivation-inhibitory (TI) domain at the C termini, which can bind to the transactivation (TA) domain and inhibit its transcriptional activity. Consequently, TAp63alpha can directly inhibit its activity through an intramolecular interaction; similarly, DeltaNp63alpha can inhibit the activity of the active TAp63 isoforms through an intermolecular interaction. In this work, we demonstrate that after induction of apoptosis, the TI domain of the p63alpha isoforms is cleaved by activated caspases. Cleavage of DeltaNp63alpha relieves its inhibitory effect on the transcriptionally active p63 proteins, and the cleavage of TAp63alpha results in production of a TAp63 protein with enhanced transcriptional activity. In agreement with these data, generation of the N-terminal TAp63 fragment has a role in apoptosis because stable cell lines expressing wild-type TAp63 are more sensitive to apoptosis compared with cells expressing the noncleavable mutant. We also used a model system in which TAp63 expression was induced by trichostatin-A treatment in HCT116 cells. Trichostatin-A sensitized these cells to apoptosis, and this sensitization was associated with cleavage of up-regulated p63.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581882      PMCID: PMC1904122          DOI: 10.1073/pnas.0700761104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification.

Authors:  Giancarlo Pruneri; Sonia Fabris; Patrizia Dell'Orto; Maria Olivia Biasi; Stefano Valentini; Barbara Del Curto; Daniele Laszlo; Laura Cattaneo; Roberta Fasani; Laura Rossini; Michela Manzotti; Francesco Bertolini; Giovanni Martinelli; Antonino Neri; Giuseppe Viale
Journal:  J Pathol       Date:  2005-07       Impact factor: 7.996

2.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

Authors:  A Yang; M Kaghad; Y Wang; E Gillett; M D Fleming; V Dötsch; N C Andrews; D Caput; F McKeon
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

3.  Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability.

Authors:  M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

4.  p63 is an essential proapoptotic protein during neural development.

Authors:  W Bradley Jacobs; Gregory Govoni; Daniel Ho; Jasvinder K Atwal; Fanie Barnabe-Heider; William M Keyes; Alea A Mills; Freda D Miller; David R Kaplan
Journal:  Neuron       Date:  2005-12-08       Impact factor: 17.173

5.  TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria.

Authors:  Olav Gressner; Tobias Schilling; Katja Lorenz; Elisa Schulze Schleithoff; Andreas Koch; Henning Schulze-Bergkamen; Anna Maria Lena; Eleonora Candi; Alessandro Terrinoni; Maria Valeria Catani; Moshe Oren; Gerry Melino; Peter H Krammer; Wolfgang Stremmel; Martina Müller
Journal:  EMBO J       Date:  2005-06-09       Impact factor: 11.598

6.  DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.

Authors:  Guojun Wu; Shuji Nomoto; Mohammad Obaidul Hoque; Tatiana Dracheva; Motonabu Osada; Chyi-Chia Richard Lee; Seung Myung Dong; Zhongmin Guo; Nicole Benoit; Yoram Cohen; Peggy Rechthand; Joseph Califano; Chul-So Moon; Edward Ratovitski; Jin Jen; David Sidransky; Barry Trink
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

7.  p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation.

Authors:  Johanna Laurikkala; Marja L Mikkola; Martyn James; Mark Tummers; Alea A Mills; Irma Thesleff
Journal:  Development       Date:  2006-03-08       Impact factor: 6.868

8.  p63 protein is essential for the embryonic development of vibrissae and teeth.

Authors:  Alessandro Rufini; Miguel Weil; Frank McKeon; Alberto Barlattani; Gerry Melino; Eleonora Candi
Journal:  Biochem Biophys Res Commun       Date:  2005-12-20       Impact factor: 3.575

9.  Calpain cleavage regulates the protein stability of p73.

Authors:  Eliana Munarriz; Daniele Bano; A Emre Sayan; Mario Rossi; Gerry Melino; Pierluigi Nicotera
Journal:  Biochem Biophys Res Commun       Date:  2005-08-05       Impact factor: 3.575

Review 10.  Functional regulation of p73 and p63: development and cancer.

Authors:  Gerry Melino; Xin Lu; Milena Gasco; Tim Crook; Richard A Knight
Journal:  Trends Biochem Sci       Date:  2003-12       Impact factor: 13.807

View more
  19 in total

1.  Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.

Authors:  Young Joo Jeon; Mi Gyeong Jo; Hee Min Yoo; Se-Hoon Hong; Jung-Mi Park; Seung Hyeun Ka; Kyu Hee Oh; Jae Hong Seol; Yong Keun Jung; Chin Ha Chung
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

2.  C-terminal cleavage of DeltaNp63alpha is associated with TSA-induced apoptosis in immortalized corneal epithelial cells.

Authors:  Danielle M Robertson; Su-Inn Ho; H Dwight Cavanagh
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

3.  Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.

Authors:  Berna S Sayan; Ai Li Yang; Franco Conforti; Paola Tucci; Maria Cristina Piro; Gareth J Browne; Massimiliano Agostini; Sergio Bernardini; Richard A Knight; Tak W Mak; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

4.  Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes.

Authors:  Ulrike Beyer; Julian Moll-Rocek; Ute M Moll; Matthias Dobbelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

Review 5.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

6.  Requirement of zinc transporter ZIP10 for epidermal development: Implication of the ZIP10-p63 axis in epithelial homeostasis.

Authors:  Bum-Ho Bin; Jinhyuk Bhin; Mikiro Takaishi; Koh-Ei Toyoshima; Saeko Kawamata; Kana Ito; Takafumi Hara; Takashi Watanabe; Tarou Irié; Teruhisa Takagishi; Su-Hyon Lee; Haeng-Sun Jung; Sangchul Rho; Juyeon Seo; Dong-Hwa Choi; Daehee Hwang; Haruhiko Koseki; Osamu Ohara; Shigetoshi Sano; Takashi Tsuji; Kenji Mishima; Toshiyuki Fukada
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-23       Impact factor: 11.205

7.  Tumour suppressor ING1b maintains genomic stability upon replication stress.

Authors:  Ronald P C Wong; Hanyang Lin; Shahram Khosravi; Brad Piche; Seyed Mehdi Jafarnejad; David W C Chen; Gang Li
Journal:  Nucleic Acids Res       Date:  2011-01-11       Impact factor: 16.971

Review 8.  Regulation of p73 activity by post-translational modifications.

Authors:  F Conforti; A E Sayan; R Sreekumar; B S Sayan
Journal:  Cell Death Dis       Date:  2012-03-15       Impact factor: 8.469

9.  Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion.

Authors:  P A J Muller; A G Trinidad; P Timpson; J P Morton; S Zanivan; P V E van den Berghe; C Nixon; S A Karim; P T Caswell; J E Noll; C R Coffill; D P Lane; O J Sansom; P M Neilsen; J C Norman; K H Vousden
Journal:  Oncogene       Date:  2012-05-14       Impact factor: 9.867

10.  Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.

Authors:  Holger Schwender; Silvia Selinski; Meinolf Blaszkewicz; Rosemarie Marchan; Katja Ickstadt; Klaus Golka; Jan G Hengstler
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.